NCT05241171 is a NA clinical trial of Fitbit in Physical Activity, sponsored by University of California, San Diego.

Who is sponsoring NCT05241171?

NCT05241171 is sponsored by University of California, San Diego.

What drugs are being tested in NCT05241171?

Interventions in NCT05241171: Fitbit.

What condition does NCT05241171 study?

NCT05241171 studies Physical Activity, End Stage Kidney Disease, Hemodialysis.

Is NCT05241171 still recruiting?

NCT05241171 is currently completed. Last updated 15 February 2022.

Last reviewed 2022-02-15 · How we verify

NCT05241171

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The "Step4Life" Randomized Control Trial in Hemodialysis

Completed NA Last updated 15 February 2022

What this trial tests

NA trial testing Fitbit in Physical Activity in 55 participants. Completed in 30 May 2020.

Timeline

1 January 2019

Primary endpoint
30 April 2020

30 May 2020

Quick facts

Lead sponsor	University of California, San Diego
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	55
Start date	1 January 2019
Primary completion	30 April 2020
Estimated completion	30 May 2020
Sites	1 location across United States

Drugs / interventions tested

Fitbit

Conditions studied

Physical Activity — all drugs for Physical Activity →
End Stage Kidney Disease — all drugs for End Stage Kidney Disease →
Hemodialysis — all drugs for Hemodialysis →

Sponsor

University of California, San Diego

Who can join

18 and older, any sex, with Physical Activity or End Stage Kidney Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Persons with end-stage kidney disease (ESKD) have very low physical activity, and among ESKD patients, the level of inactivity is strongly associated with morbidity and mortality. This study aimed to assess the feasibility and effectiveness of a 12-week intervention coupling use of wearable pedometers (FitBit ®) and feedback coaching to increase physical activity in hemodialysis patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Impact of a Wearable Activity Tracker and Structured Feedback Program on Physical Activity in Hemodialysis Patients: The Step4Life Pilot Randomized Controlled Trial.
Malhotra R, Rahimi S, Agarwal U, Katz R, et al · · 2023 · cited 14× · PMID 36801430 · DOI 10.1053/j.ajkd.2022.12.011

Verify or expand the search:

Other trials of Fitbit

Trials testing the same drug.

NCT07345767 — Hypknowledge Nationwide Sleep Extension · NA · recruiting
NCT07140770 — Sleep and Physical Activity in Patient and Caregiver Dyads Following Allogeneic Hematopoietic Cell Transplantation · recruiting
NCT06919471 — Assessing User Satisfaction and Adherence to an Abbreviated Dietary Tracking App (MySnackTracker) Versus Full-intake Die · NA · recruiting
NCT06587100 — Wearable Activity Tracking to Curb Hospitalizations · recruiting
NCT06534918 — Precise Oncology Interventions in Nutrition and Training (OnPoint) · NA · recruiting

Other recruiting trials for Physical Activity

Currently open trials in the same condition.

NCT07466797 — The eHealth Integrated Maternal Physical Activity Programme in Prenatal Care Trial (E-IMPACT) · NA · recruiting
NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
NCT07290309 — Survivors Uniting for Remote Guided Exercise · NA · recruiting
NCT07415460 — Evaluating the Impact of SKY Breath Meditation on Stress, Well-being, and Connection in College Students · NA · recruiting
NCT07585409 — Physical Activity in Persons With Parkinson's Disease · recruiting

Other University of California, San Diego trials

Trials by the same sponsor.

NCT07342543 — Guided Physical Activity Counseling for Hypertension in Primary Care · NA · not yet recruiting
NCT06505317 — Artificial Intelligence for Early Detection of Peripheral Artery Disease · NA · not yet recruiting
NCT07211802 — CKM For Safe Use of SGLT2i in Type 1 Diabetes · Phase 3 · not yet recruiting
NCT07524751 — Culturally Adapted Pain Management for Indigenous Peoples · NA · not yet recruiting
NCT07518784 — Accurate Point of Care Liver Disease Diagnostics (Phase 2) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05241171 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, San Diego
Last refreshed: 15 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05241171.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing